A recent report published by Infinium Global Research on minimally invasive glaucoma surgery (MIGS) devices market provides an in-depth analysis of segments and sub-segments in the global as well as regional minimally invasive glaucoma surgery devices market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional minimally invasive glaucoma surgery devices market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global minimally invasive glaucoma surgery devices market. According to the report, the global minimally invasive glaucoma surgery devices market is projected to grow at a CAGR of 24.6% over the forecast period of 2019-2025.
The
development of minimally invasive glaucoma surgery devices has changed patient
care with mild-to-moderate glaucoma conditions. Minimally Invasive Glaucoma
Surgery (MIGS) is a surgical procedure performed on patients suffering from
glaucoma. MIGS is a safer and effective surgery as compared to conventional
open surgery or laser surgery. Unlike conventional surgeries, MIGS is
associated with lesser risks. The microscopic tools and equipment that are
administered through lesser invasive means in the glaucoma treatment are known
as MIGS devices. MIGS devices come in various forms including stents, shunts
and other forms.
Factors such
as the increase in the geriatric population, rise in the prevalence of
ophthalmic disorders and subsequent blindness are the major drivers for the
global MIGS devices market. Cataract and glaucoma are the two most prevailing
eye-diseases that arise with growing age, which are one of the major causes of
blindness in the aged population. Moreover, increasing demand for combined
glaucoma and cataract treatment due to technological advancement in devices and
growing awareness about minimally invasive surgeries among the patients are
factors pushing the growth of MIGS devices market further. Additionally, the
major players in the ophthalmic treatment market are more focused on developing
MIGS stent for more effective treatment. This in return is expected to boost
the demand for MIGS devices. However, poor reimbursement scenario and the
dearth of experienced and skilled professionals are some of the factors that
may hinder the growth of the global MIGS devices market. Nevertheless, the
trend in glaucoma therapy is been observed to shift from conventional
medication to minimally invasive surgeries, which is anticipated to provide
lucrative opportunities to the companies in the MIGS devices market.
Geographically,
the global MIGS devices market is divided into four major regions including,
North America, Europe, Asia Pacific and the Rest of the World. The North
American region dominated the global MIGS devices market accounting for the
highest market share. The large share of the North American region attributes
to the increase in the geriatric population, availability of better healthcare
infrastructure and the presence of key players in the market. However, the
market in the Asia Pacific region registered the fastest growth rate owing to the
large population base suffering from ophthalmic diseases, growing demand for
minimally invasive surgeries and a rise in the government expenditure on
healthcare.
The report on
global minimally invasive glaucoma surgery devices market covers segments such
as surgery, target, product, and end-users. On the basis of surgery, the
sub-markets include glaucoma in conjunction with cataract, and stand alone
glaucoma. On the basis of target, the sub-markets include trabecular meshwork,
suprachoroidal space, and other targets. On the basis of product, the
sub-markets include MIGS stents, MIGS shunts, and other products. On the basis
of end-users, the sub-markets include hospitals, ophthalmology clinics, and
ambulatory surgical centers.
The report
provides profiles of the companies in the market such as Alcon Vision LLC,
Allergan PLC, Bausch & Lomb Inc, Carl Zeiss Meditec, Inc., Ellex
Medical Lasers Ltd, Glaukos Corp, Ivantis, Inc., Lumenis Ltd., Santen
Pharmaceutical Co., Ltd., and SOLX, Inc.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of minimally invasive glaucoma surgery devices
market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.